3,6,9,12,15,18,21,24,27,30,33,36,39,42-tetradecaoxatetratetracontane-1,44-diol

3,6,9,12,15,18,21,24,27,30,33,36,39,42-tetradecaoxatetratetracontane-1,44-diol 구조식 이미지
카스 번호:
28821-35-4
상품명:
3,6,9,12,15,18,21,24,27,30,33,36,39,42-tetradecaoxatetratetracontane-1,44-diol
동의어(영문):
PEG15;HO-PEG15-OH;OH-PEG15-OH;CAS_28821-35-4;pentadecaethylene glycol;3,6,9,12,15,18,21,24,27,30,33,36,39,42-tetradecaoxatetratetracontane-1,44-diol;HO-PEG15-OH/3,6,9,12,15,18,21,24,27,30,33,36,39,42-Tetradecaoxatetratetracontane-1,44-diol
CBNumber:
CB4919252
분자식:
C30H62O16
포뮬러 무게:
678.8
MOL 파일:
28821-35-4.mol

3,6,9,12,15,18,21,24,27,30,33,36,39,42-tetradecaoxatetratetracontane-1,44-diol 속성

끓는 점
687.9±50.0 °C(Predicted)
밀도
1.116±0.06 g/cm3(Predicted)
산도 계수 (pKa)
14.06±0.10(Predicted)

안전

3,6,9,12,15,18,21,24,27,30,33,36,39,42-tetradecaoxatetratetracontane-1,44-diol C화학적 특성, 용도, 생산

3,6,9,12,15,18,21,24,27,30,33,36,39,42-tetradecaoxatetratetracontane-1,44-diol 준비 용품 및 원자재

원자재

준비 용품


3,6,9,12,15,18,21,24,27,30,33,36,39,42-tetradecaoxatetratetracontane-1,44-diol 공급 업체

글로벌( 46)공급 업체
공급자 전화 이메일 국가 제품 수 이점
SHANGHAI T&W PHARMACEUTICAL CO., LTD.
+86-021-61551413 +8618813727289
contact@trustwe.com China 5738 58
TargetMol Chemicals Inc.
+1-781-999-5354 +1-00000000000
marketing@targetmol.com United States 19892 58
Wuhan Borenpharm Co., Ltd
027-65563561 18717150066
3207347307@qq.com CHINA 1238 58
Hangzhou MolCore BioPharmatech Co.,Ltd.
+86-057181025280; +8617767106207
sales@molcore.com China 49739 58
GIHI CHEMICALS CO.,LIMITED
+8618058761490
info@gihichemicals.com China 50000 58
Jilin Chinese Academy of Sciences-yanshen Technology
+undefined18143011203
info@chemextension.com China 42057 58
Aladdin Scientific
+1-833-552-7181
sales@aladdinsci.com United States 52927 58
Alabiochem Tech.Co., Ltd. 0512-58900862 400-0707518
sales@alabiochem.com China 995 59
T&W GROUP 021-61551611 13296011611
contact@trustwe.com China 9900 58
Nanjing Anyan Pharmaceutical Technology Co. , Ltd. 18136859766
amy.xiang@ally-chem.com China 330 60

Copyright 2019 © ChemicalBook. All rights reserved